Track ipamorelin in Peptimes™
Ipamorelin is a synthetic peptide of five amino acids, two of them non-standard: Aib-His-D-2-Nal-D-Phe-Lys-NH2. FDA's substance registry also lists it as NNC 26-0161. (Source: FDA's substance registry (GSRS).)
Is ipamorelin FDA-approved?
No. Ipamorelin isn't FDA-approved: Drugs@FDA lists no application with it, and FDA puts ipamorelin acetate on its Category 2 list of bulk substances for compounding that may present significant safety risks.
Ipamorelin
Also: NNC 26-0161, ipamorelin acetate
- Status label in the Peptimes Library
- Compounding Restricted
- Routes in Peptimes
- Subcutaneous
- Updated
- 1 Nov 2026
US regulatory status
FDA status
Not FDA-Approved. Drugs@FDA lists no application with ipamorelin as an active ingredient.
Source: Drugs@FDA, checked 1 Nov 2026
FDA status
On FDA's Category 2 list: FDA lists ipamorelin acetate among bulk drug substances for compounding that may present significant safety risks, under its interim policy for outsourcing facilities (503B), added 29 Sep 2023.
Source: FDA, checked 1 Nov 2026
What studies have looked at
Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.
- In humans
In a placebo-controlled study in healthy men, ipamorelin caused a single burst of growth hormone release that peaked within an hour and then fell to negligible levels, in every group studied.
Source: PMID 10496658, checked 1 Nov 2026
How to track it in Peptimes
Add ipamorelin in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Compounding Restricted”, the app’s label for compounds on FDA’s Category 2 list. Category 2 is FDA’s list of bulk drug substances for compounding that may present significant safety risks; it is not an approval.
- Logging: the amount you took and how you feel.
- Injection sites: each dose records the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell ipamorelin or any other compound.
More sources
- FDA, Certain bulk drug substances for use in compounding that may present significant safety risks, checked 1 Nov 2026: ipamorelin acetate, 503B, added 29 Sep 2023.
- FDA, Global Substance Registration System, Ipamorelin, checked 1 Nov 2026: its sequence and the name NNC 26-0161.
- ClinicalTrials.gov, searched 1 Nov 2026: two Phase 2 studies of ipamorelin, both completed.